CLDF Title
Contact Us | Bookmark
  HBV   HCC   HCV   HE   HEPATORENAL SYNDROME   NASH   PBC   THROMBOCYTOPENIA
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
      IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Levels of liver fat biomarker tied to metabolic benefits of exercise
06-11-2019
Early TIPS improves outcomes in cirrhosis with variceal bleeding
06-11-2019
'Liquid biopsy' for pediatric fatty liver disease on the horizon
06-10-2019
Laparoscopic on par with open surgery for colorectal-cancer liver metastases
06-05-2019
Vedolizumab likely unhelpful for extra-intestinal manifestations of IBD
06-03-2019
New therapy improves survival in hepatoma with portal-vein invasion
05-28-2019
Cirrhosis, cancer risks higher with NAFLD- especially in diabetics
05-27-2019
Rare pregnancy complication linked to non-alcoholic fatty liver disease
05-20-2019
Sunday is 'Hepatitis Testing Day'
05-17-2019
Reanalysis of tenofovir study changes some findings
05-13-2019
Worse outcomes for patients not achieving sustained viral remission after HCV treatment
05-07-2019
China seeks loophole as UN nears pact banning toxic chemical - activists
05-01-2019
Gilead's NASH drug fails to meet late-stage study goal
04-25-2019
Whole exome sequencing shows promise in diagnosing unexplained liver disease
04-24-2019
View Complete News Library
 
 
June 27-29, 2019
ALEH - Latinamerican Association for the Study of the Liver-Congreso Hepato
Recoleta, Argentina
July 20-21, 2019
NCCHC - National Commission on Correctional Health Care
Las Vegas, NV, USA
August 9-10, 2019
Advanced Hepatology Educational Summit for 3rd Year Fellows
Chicago, IL, USA
August 15-18, 2019
NCAD - National Conference on Addiction Disorders- NCAD EAST
Baltimore, MD, USA
September 5-7, 2019
GHAPP - Gastroenterology & Hepatology Advanced Practice Providers
Las Vegas, NV, USA
October 2-6, 2019
IDSA - Infectious Diseases Society of America- ID Week
Washington, DC, USA
October 19-23, 2019
AATOD - American Association for the Treatment of Opioid Dependence
Orlando, FL, USA
October 19-23, 2019
UEGW - United European Gastroenterology Week
Barcelona, Spain
October 25-30, 2019
ACG - American College of Gastroenterology
San Antonio, TX, USA
October 24-26, 2019
NCAD - National Conference on Addiction Disorders- NCAD WEST
Denver, CO, USA
November 5-7, 2019
Obesity Week - American Society for Metabolic and Bariatric Surgery
Las Vegas, NV, USA
View all Congresses
 
 
 
 
 
 
 
 
 
  Line  
  Featured Abstracts          
 
Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis
 
Hepatitis B and C virus infection as a risk factor for Parkinson
 
Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation
 
Maintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in patients with chronic hepatitis B
 
Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston
 
Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting
 
Health implications of sex trading characteristics in Long Beach, California, USA
 
Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2
 
HIV and HCV screening among trauma patients
 
Renal Failure in Patients with Liver Cirrhosis: Novel Classifications, Biomarkers, Treatment
 
Hepatorenal Syndrome: Physiology, Diagnosis and Management
 
Renal Function in Cirrhosis: A Critical Review of Available Tools
 
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome
 
Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis
 
Countdown to 2030: eliminating hepatitis B disease, China
 
A global scientific strategy to cure hepatitis B
 
Hepatitis B Virus and HIV Coinfection: Fibrosis, Fat, and Future Directions
 
Treatment of Viral Infections During Pregnancy
 
Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis
 
Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States
 
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
 
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
 
 
Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy
 
Gender disparity in HCC: Is it the fat and not the sex?
 
Lenvatinib: A Review in Hepatocellular Carcinoma
 
Hepatitis C in pregnant American Indian and Alaska native women; 2003-2015
 
Hepatitis C Virus Treatment with Directly Acting Agents Reduces the Risk of Incident Diabetes - Results from ERCHIVES
 
Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned
 
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection and Psychiatric Disorders: An Integrated Analysis
 
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
 
The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials
 
A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease
 
Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease
 
Prevalence of non-alcoholic fatty liver disease on computed tomography in patients with inflammatory bowel disease visiting an emergency department
 
Past, present and future perspectives in nonalcoholic fatty liver disease
 
Biology of portal hypertension
 
Well Preserved Renal Function in Children With Untreated Chronic Liver Disease
 
Hepatorenal syndrome: the clinical impact of vasoactive therapy
 
The emergency medicine evaluation and management of the patient with cirrhosis
 
Favorable Response of Metastatic Hepatocellular Carcinoma to Treatment with Trans-arterial Radioembolization Followed by Sorafenib and Nivolumab
 
Management Approaches to Hepatitis B Virus Vaccination Nonresponse
 
Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis
 
Liver Fibrosis Determination
 
Quantitative evaluation of an integrated nurse model of care providing hepatitis Ctreatment to people attending homeless services in Melbourne, Australia
 
 
Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study
 
Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs
 
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study
 
Coffee consumption by type and risk of digestive cancer: a large prospective cohort study
 
Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents
 
Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review
 
Insurance status impacts treatment for hepatocellular carcinoma
 
A prospective study of nut consumption and risk of primary hepatocellular carcinoma in the U.S. women and men
 
The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records
 
Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome
 
Acute kidney injury in cirrhosis: implications for liver transplantation
 
Outcomes of renal dysfunction in patients with acute liver failure
 
Effect of Renal Diagnosis on Survival in Simultaneous Liver-Kidney Transplantation
 
Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample
 
L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
 
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy
 
How to Design a Multicenter Clinical Trial in Hepatic Encephalopathy
 
Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis
 
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution
 
Helicobacter pylori infection and NAFLD
 
Prevalence of nocturia and fecal and urinary incontinence and the association to childhood obesity: a study of 6803 Danish school children
 
Hepatorenal Syndrome
 
 
Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multi-Center Study
 
 
          View All Abstracts  
  Line  
                               
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
Hepatorenal Syndrome
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
OTHER
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.